Decoding TRIP13’s Role in Gastric Cancer: Implications for Prognosis and Immune Response
Open Access
- 15 September 2025
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 13 (9) , 2268
Abstract
Background/Objectives: Gastric cancer (GC), a prevalent global malignancy and a leading cause of cancer-related mortality, has a poorly understood prognosis related to TRIP13 expression. TRIP13 has a recognized part in driving tumor progression across different cancer types, yet its precise role in GC remains beyond our full comprehension. Our study aimed to explore TRIP13’s prognostic value and function in GC patients. Methods: We extensively explored TRIP13’s influence on GC prognosis, functionality, and immune response by examining various cancer-related databases like UALCAN, GEPIA, GEO, and TIMER. Immunohistochemistry (IHC) staining was also conducted to assess the link between TRIM13 and GC patient survival. Results: TRIP13 expression levels were found to be significantly elevated in GC tissues compared to normal tissues through analysis of mRNA data from multiple public databases. IHC analysis exposed elevated TRIP13 protein levels in GC tissues and connected it with tumor depth. Prognostic evaluation demonstrated that GC patients exhibiting heightened TRIP13 expression endured a diminished overall survival rate. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses showed that genes related to TRIP13 are involved in processes such as the cell cycle and DNA repair. Additionally, TRIP13 expression was found to correlate with ferroptosis-related genes and may play a role in regulating ferroptosis. Immune cell infiltration analysis demonstrated that TRIP13 expression is negatively correlated with the infiltration of CD4+ T cells, CD8+ T cells, and B cells. Conclusions: TRIP13 emerges as a candidate independent prognostic indicator and a promising intervention point for GC treatment.Keywords
Funding Information
- Collaborative custom development of RNA probes (P112213323)
This publication has 40 references indexed in Scilit:
- Role of TRIP13 in human cancer developmentMolecular Biology Reports, 2024
- TRIP13: A promising cancer immunotherapy targetCancer Innovation, 2024
- Gastric cancer derived exosomal THBS1 enhanced Vγ9Vδ2 T-cell function through activating RIG-I-like receptor signaling pathway in a N6-methyladenosine methylation dependent mannerCancer Letters, 2023
- TRIP13 overexpression in hepatocellular carcinoma: implications for poor prognosis and immune cell infiltrationDiscover Oncology, 2023
- ggClusterNet: An R package for microbiome network analysis and modularity‐based multiple network layoutsiMeta, 2022
- TRIP13 exerts a cancer‐promoting role in cervical cancer by enhancing Wnt/β‐catenin signaling via ACTN4Environmental Toxicology, 2021
- TRIP13 promotes the proliferation and invasion of lung cancer cells via the Wnt signaling pathway and epithelial–mesenchymal transitionJournal of Molecular Histology, 2020
- TRIP13 promotes metastasis of colorectal cancer regardless of p53 and microsatellite instability statusMolecular Oncology, 2020
- TRIP13 interference inhibits the proliferation and metastasis of thyroid cancer cells through regulating TTC5/p53 pathway and epithelial-mesenchymal transition related genes expressionBiomedicine & Pharmacotherapy, 2019
- Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of OriginCell, 2014